Orchestra BioMed Holdings Inc. Cash Flow Quality Index

Latest as of December 2025: -0.36x

Orchestra BioMed Holdings Inc. cash flow quality index. Orchestra BioMed Holdings Inc. (OBIO) has a Cash Flow Quality Index of -0.36x as of December 2025. Operating cash flow of $-2.27 Million is below net income of $6.25 Million, suggesting accrual-heavy earnings not yet converted to cash. See Orchestra BioMed Holdings Inc. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.36x
Operating CF / Net Income

Operating Cash Flow

$-2.27 Million
USD

Net Income

$6.25 Million
USD

Data as of

Dec 2025
Most recent filing

Orchestra BioMed Holdings Inc. Cash Flow Quality Index by Year (None–None)

Orchestra BioMed Holdings Inc. cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Orchestra BioMed Holdings Inc.. For the full cash flow conversion analysis, see OBIO operating cash flow.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.